The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Oxidative stress and inflammation in iron‐overloaded patients with β‐thalassaemia or sickle cell disease
Open accessAbstract
Summary: Blood transfusion therapy is life‐saving for patients with β‐thalassaemia and sickle cell disease (SCD), but often results in severe iron overload. This pilot study examined whether the biomarkers of tissue injury or inflammation differ in these two diseases. Plasma malondialdehyde (MDA) was significantly increased 1·8‐fold in thalassaemia relative to control patients. In contrast, MDA in SCD was not significantly different from controls. In multivariate analysis, the strongest predictors of elevated MDA were liver iron concentration (P < 0·001) and specific diagnosis (P = 0·019). A significant 2‐fold elevation of non‐transferrin bound iron (NTBI) was observed in thalassaemia relative to SCD. NTBI was not a significant predictor of high MDA in multivariate analysis. SCD patients showed a significant 2·2‐fold elevation of the inflammatory marker interleukin (IL)‐6 relative to controls, and a 3·6‐ and 1·7‐fold increase in IL‐5 and IL‐10 relative to thalassaemia. Although α‐tocopherol was significantly decreased by at least 32% in both thalassaemia and SCD, indicating ongoing oxidant stress and antioxidant consumption, γ‐tocopherol, a nitric oxide‐selective antioxidant, was increased 36% in SCD relative to thalassaemia. These results demonstrate that thalassaemia patients have increased MDA and circulating NTBI relative to SCD patients and lower levels of some cytokines and γ‐tocopherol. This supports the hypothesis that the biology of SCD may show increased inflammation and increased levels of protective antioxidants compared with thalassaemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330 · cited 1×
“These increased oxidants and intravascular haemoglobin from haemolysis (Reiter et al, 2002) may contribute to the consumption of nitric oxide in SCD (Aslan et al, 2001).”
Backgroundγ-Tocopherol, the major form of vitamin E in the US diet, deserves more attention
Jiang, Q., Christen, S., Shigenaga, M. K., & Ames, B. N. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.6.714 · Cited by 776 · cited 1×
“…as an oxygen radical scavenger, c-tocopherol scavenges reactive nitric oxide species and inhibits prostaglandin E2-mediated inflammation (Jiang et al, 2000, 2001, 2002; Jiang & Ames, 2003). c-Tocopherol, in contrast to atocopherol, is increased in response to inflammatory stimuli…”
BackgroundSelf-citationKadiiska, M. B., Gladen, B. C., Baird, D. D., Germolec, D., Graham, L. B., Parker, C. E., Nyska, A., Wachsman, J. T., Ames, B. N., Basu, S., et al. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.09.017 · Cited by 697
Self-citationSURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR
Zurlo, M., De Stefano, P., Borgna-Pignatti, C., Di Palma, A., Melevendi, C., Piga, A., Di Gregorio, F., Burattini, M., & Terzoli, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90264-x · Cited by 611
Christen, S., Woodall, A. A., Shigenaga, M. K., Southwell-Keely, P. T., Duncan, M. W., & Ames, B. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3217 · Cited by 537
Jiang, Q., Elson-Schwab, I., Courtemanche, C., & Ames, B. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200357097 · Cited by 523
Self-citationCytochrome P450 ω-Hydroxylase Pathway of Tocopherol Catabolism
Sontag, T. J., & Parker, R. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201466200 · Cited by 458
Complications of β-thalassemia major in North America
Cunningham, M. J., Macklin, E. A., Neufeld, E. J., Cohen, A. R., & the Thalassemia Clinical Research Network (2004) · Blood · doi:10.1182/blood-2003-09-3167 · Cited by 454
Hepcidin in iron overload disorders
Papanikolaou, G., Tzilianos, M., Christakis, J. I., Bogdanos, D., Tsimirika, K., MacFarlane, J., Goldberg, Y. P., Sakellaropoulos, N., Ganz, T., & Nemeth, E. (2005) · Blood · doi:10.1182/blood-2004-12-4844 · Cited by 445 · cited 1×
“Recently, hepcidin that is increased in inflammation, has been identified as a critical participant in this cellular regulation of iron storage (Papanikolaou et al, 2005).”
BackgroundCytokine-mediated regulation of iron transport in human monocytic cells
Ludwiczek, S., Aigner, E., Theurl, I., & Weiss, G. (2003) · Blood · doi:10.1182/blood-2002-08-2459 · Cited by 420
Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease
Aslan, M., Ryan, T. M., Adler, B., Townes, T. M., Parks, D. A., Thompson, J. A., Tousson, A., Gladwin, M. T., Patel, R. P., Tarpey, M. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221292098 · Cited by 391
Iron metabolism in health and disease
Baldus, W. P. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90247-3 · Cited by 377
Belcher, J. D., Marker, P. H., Weber, J. P., Hebbel, R. P., & Vercellotti, G. M. (2000) · Blood · doi:10.1182/blood.v96.7.2451 · Cited by 367
Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats
Walter, P. B., Knutson, M. D., Paler-Martinez, A., Lee, S., Xu, Y., Viteri, F. E., & Ames, B. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261708798 · Cited by 359
Self-citationSurvival and Disease Complications in Thalassemia Major
BORGNA‐PIGNATTI, C., RUGOLOTTO, S., DE STEFANO, P., PIGA, A., DI GREGORIO, F., GAMBERINI, M. R., SABATO, V., MELEVENDI, C., CAPPELLINI, M. D., & VERLATO, G. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10479.x · Cited by 343
Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease
Wood, J. C., Tyszka, J. M., Carson, S., Nelson, M. D., & Coates, T. D. (2004) · Blood · doi:10.1182/blood-2003-06-1919 · Cited by 341
Jiang, Q., & Ames, B. N. (2003) · The FASEB Journal · doi:10.1096/fj.02-0877com · Cited by 321
Self-citationDivergent Nitric Oxide Bioavailability in Men and Women With Sickle Cell Disease
Gladwin, M. T., Schechter, A. N., Ognibene, F. P., Coles, W. A., Reiter, C. D., Schenke, W. H., Csako, G., Waclawiw, M. A., Panza, J. A., & Cannon, R. O. (2003) · Circulation · doi:10.1161/01.cir.0000044943.12533.a8 · Cited by 273
Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload.
Houglum, K., Filip, M., Witztum, J. L., & Chojkier, M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114934 · Cited by 254
Kushner, J. P., Porter, J. P., & Olivieri, N. F. (2001) · Hematology · doi:10.1182/asheducation-2001.1.47 · Cited by 245
Self-citationTransgenic sickle mice have vascular inflammation
Belcher, J. D., Bryant, C. J., Nguyen, J., Bowlin, P. R., Kielbik, M. C., Bischof, J. C., Hebbel, R. P., & Vercellotti, G. M. (2003) · Blood · doi:10.1182/blood-2002-10-3313 · Cited by 242
Liu, J., Yeo, H. C., Doniger, S. J., & Ames, B. N. (1997) · Analytical Biochemistry · doi:10.1006/abio.1996.9990 · Cited by 229
Jison, M. L., Munson, P. J., Barb, J. J., Suffredini, A. F., Talwar, S., Logun, C., Raghavachari, N., Beigel, J. H., Shelhamer, J. H., Danner, R. L., et al. (2004) · Blood · doi:10.1182/blood-2003-08-2760 · Cited by 221
Cytochrome P4503A-Dependent Metabolism of Tocopherols and Inhibition by Sesamin
Parker, R. S., Sontag, T. J., & Swanson, J. E. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3706 · Cited by 213
Scott, M. D., van den Berg, J. J., Repka, T., Rouyer-Fessard, P., Hebbel, R. P., Beuzard, Y., & Lubin, B. H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116380 · Cited by 204
Biomarkers of oxidative stress study
Kadiiska, M. B., Gladen, B. C., Baird, D. D., Graham, L. B., Parker, C. E., Ames, B. N., Basu, S., FitzGerald, G. A., Lawson, J. A., Marnett, L. J., et al. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.10.024 · Cited by 196
Self-citationKinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy
Porter, Abeysinghe, R., Marshall, L., Hider, R., & Singh, S. (1996) · Blood · doi:10.1182/blood.v88.2.705.bloodjournal882705 · Cited by 187
Lipid membrane peroxidation in beta-thalassemia major
Rachmilewitz, E., Shohet, S., & Lubin, B. (1976) · Blood · doi:10.1182/blood.v47.3.495.495 · Cited by 182
Urinary hepcidin in congenital chronic anemias
Kearney, S. L., Nemeth, E., Neufeld, E. J., Thapa, D., Ganz, T., Weinstein, D. A., & Cunningham, M. J. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.20616 · Cited by 172 · cited 1×
“In transfused thalassaemia or SCD patients the hepicidin level may vary depending on the severity of anaemia as suggested in a recent study (Kearney et al, 2005).”
BackgroundEffect of Age at the Start of Iron Chelation Therapy on Gonadal Function in β-Thalassemia Major
Bronspiegel-Weintrob, N., Olivieri, N. F., Tyler, B., Andrews, D. F., Freedman, M. H., & Holland, F. J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009133231104 · Cited by 171
Both Iron Deficiency and Daily Iron Supplements Increase Lipid Peroxidation in Rats
Knutson, M. D., Walter, P. B., Ames, B. N., & Viteri, F. E. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.3.621 · Cited by 168
Self-citationQuantification of Non-Transferrin-Bound Iron in the Presence of Unsaturated Transferrin
Gosriwatana, I., Loreal, O., Lu, S., Brissot, P., Porter, J., & Hider, R. C. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4216 · Cited by 168
Self-citationNitric Oxide-dependent Generation of Reactive Species in Sickle Cell Disease
Aslan, M., Ryan, T. M., Townes, T. M., Coward, L., Kirk, M. C., Barnes, S., Alexander, C. B., Rosenfeld, S. S., & Freeman, B. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208916200 · Cited by 167
Oxidative status and malondialdehyde in β‐thalassaemia patients
Cighetti, G., Duca, L., Bortone, L., Sala, S., Nava, I., Fiorelli, G., & Cappellini, M. D. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.0320s1055.x · Cited by 159
Phagocytosis of sickle erythrocytes: immunologic and oxidative determinants of hemolytic anemia
Hebbel, R., & Miller, W. (1984) · Blood · doi:10.1182/blood.v64.3.733.733 · Cited by 158
Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia
Kassab-Chekir, A., Laradi, S., Ferchichi, S., Khelil, A. H., Feki, M., Amri, F., Selmi, H., Béjaoui, M., & Miled, A. (2003) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.07.010 · Cited by 158
A direct method for quantification of non-transferrin-bound iron
Singh, S., Hider, R. C., & Porter, J. B. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90088-q · Cited by 152
Self-citationAssay of Malondialdehyde in Biological Fluids by Gas Chromatography-Mass Spectrometry
Yeo, H.-R., Helbock, H. J., Chyu, D. W., & Ames, B. N. (1994) · Analytical Biochemistry · doi:10.1006/abio.1994.1355 · Cited by 148
Evans, R. W., & Williams, J. (1978) · Biochemical Journal · doi:10.1042/bj1730543 · Cited by 148
Fillet, G., Beguin, Y., & Baldelli, L. (1989) · Blood · doi:10.1182/blood.v74.2.844.844 · Cited by 144
Comparison of organ dysfunction in transfused patients with SCD or β thalassemia
Vichinsky, E. P., Butensky, E., Fung, E. B., Hudes, M. L., Theil, E. C., Ferrell, L. D., Williams, R., Louie, L. G., Lee, P., & Harmatz, P. (2005) · American Journal of Hematology · doi:10.1002/ajh.20402 · Cited by 137
Self-citationReactive Species in Sickle Cell Disease
ASLAN, M., THORNLEY‐BROWN, D., & FREEMAN, B. A. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06201.x · Cited by 136 · cited 1×
“Further sources of oxidants unique to SCD vasculature include xanthine oxidase released from the liver, nitric oxide and secondary oxides of nitrogen (Aslan et al, 2001, 2003; Aslan & Freeman, 2004, Aslan et al, 2000) and endothelial NADPH oxidase (Wood et al, 2005).”
BackgroundWood, K. C., Hebbel, R. P., & Granger, D. N. (2005) · The FASEB Journal · doi:10.1096/fj.04-3218fje · Cited by 135
Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease
Klings, E. S., & Farber, H. W. (2001) · Respiratory Research · doi:10.1186/rr70 · Cited by 132
Changes in the Epidemiology of Thalassemia in North America: A New Minority Disease
Vichinsky, E. P., Macklin, E. A., Waye, J. S., Lorey, F., & Olivieri, N. F. (2005) · PEDIATRICS · doi:10.1542/peds.2005-0843 · Cited by 131
Self-citationRepka, T. L., & Hebbel, R. (1991) · Blood · doi:10.1182/blood.v78.10.2753.2753 · Cited by 127
Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease
Himmelfarb, J., Kane, J., McMonagle, E., Zaltas, E., Bobzin, S., Boddupalli, S. S., Phinney, S. D., & Miller, G. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00151.x · Cited by 126
Houglum, K., Ramm, G. A., Crawford, D. H., Witztum, J. L., Powell, L. W., & Chojkier, M. (1997) · Hepatology · doi:10.1002/hep.510260311 · Cited by 122
Jiang, Q., Lykkesfeldt, J., Shigenaga, M. K., Shigeno, E. T., Christen, S., & Ames, B. N. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01091-2 · Cited by 121
Self-citationJain, S. K., & Shohet, S. B. (1984) · Blood · doi:10.1182/blood.v63.2.362.362 · Cited by 112
Non‐transferrin‐bound iron induced by myeloablative chemotherapy
Bradley, S., Gosriwitana, I., Srichairatanakool, S., Hider, R. C., & Porter, J. B. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.4143221.x · Cited by 111
Self-citationRuhl, C. E., & Everhart, J. E. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00395-0 · Cited by 107
Acute phase proteins and interleukins in steady state sickle cell disease
Bourantas, K. L., Dalekos, G. N., Makis, A., Chaidos, A., Tsiara, S., & Mavridis, A. K. (1998) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1998.tb01060.x · Cited by 105
Jacobs, E. M. G., Hendriks, J. C. M., van Tits, B. L. J. H., Evans, P. J., Breuer, W., Liu, D. Y., Jansen, E. H. J. M., Jauhiainen, K., Sturm, B., Porter, J. B., et al. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.03.008 · Cited by 101 · cited 1×
“…finding by several groups independent of the method used to measure NTBI (Singh et al, 1990; Porter et al, 1996; Bradley et al, 1997; Gosriwatana et al, 1999; Wickramasinghe et al, 1999; Jacobs et al, 2005), arises when the transferrin saturation in samples is less than 50% (Jacobs et al, 2005).”
MethodSelf-citationShalev, O., Repka, T. L., Goldfarb, A. W., Grinberg, L. N., Abrahamov, A., Olivieri, N. F., Rachmilewitz, E. A., & Hebbel, R. (1995) · Blood · doi:10.1182/blood.v86.5.2008.bloodjournal8652008 · Cited by 94
Block, G., Norris, J. C., Mandel, R., & DiSogra, C. (1995) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(95)00048-8 · Cited by 90
Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells
Banerjee, T., & Kuypers, F. A. (2004) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04781.x · Cited by 90
Oxidative Modification of Low-Density Lipoprotein and Atherogenetic Risk in β-Thalassemia
Livrea, M. A., Tesoriere, L., Maggio, A., D’Arpa, D., Pintaudi, A. M., & Pedone, E. (1998) · Blood · doi:10.1182/blood.v92.10.3936 · Cited by 86
Blood antioxidant status and urinary levels of catecholamine metabolites in β -thalassemia
Luca, C. D., Filosa, A., GRANDINETTI, M., Maggio, F. D., Lamba, M., & Passi, S. (1999) · Free Radical Research · doi:10.1080/10715769900300491 · Cited by 80
Aslan, M., & Freeman, B. A. (2004) · PubMed · Cited by 63
Peroxynitrite formation and apoptosis in transgenic sickle cell mouse kidneys
Bank, N., Kiroycheva, M. K., Ahmed, F., Anthony, G. M., Fabry, M. E., Nagel, R. L., & Singhal, P. C. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00148.x · Cited by 62
Determinants of plasma vitamin E in healthy males.
Sinha, R. R., Patterson, B. H., Mangels, A. R., et al. (1993) · PubMed · Cited by 51
Iron status and oxidative stress in β‐thalassemia patients in Jakarta
Laksmıtawatı, D. R., Handayani, S., Freisleben, S. K. U., Kurniati, V., Adhiyanto, C., Hidayat, J., Kusnandar, S., Dillon, H. S. D., Munthe, B. G., Wirawan, R., et al. (2003) · BioFactors · doi:10.1002/biof.5520190107 · Cited by 39
Effects of Deferiprone on Immune Status and Cytokine Pattern in Thalassaemia major
Vecchio, G. C. D., SCHETTINI, F., Piacente, L., Santis, A. D., Giordano, P., & Mattia, D. D. (2002) · Acta Haematologica · doi:10.1159/000064705 · Cited by 38
Alpha-2-Macroglobulin and Interleukin-6 Levels in Steady-State Sickle Cell Disease Patients
Makis, A. C., Hatzimichael, E. C., Mavridis, A. K., & Bourantas, K. L. (2000) · Acta Haematologica · doi:10.1159/000046509 · Cited by 37
Yeo, H. C. H., Liu, J., Helbock, H. J., & Ames, B. N. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)00115-9 · Cited by 36
Exercise in Sickle Cell Anemia: Effect on Inflammatory and Vasoactive Mediators
Barbeau, P., Woods, K. F., Ramsey, L. T., Litaker, M. S., Pollock, D. M., Pollock, J. S., Callahan, L. A., Kutlar, A., Mensah, G. A., & Gutin, B. (2001) · Endothelium · doi:10.3109/10623320109165323 · Cited by 35
Is there a correlation between raised erythropoietin and thrombotic events in sickle-cell anaemia?
Dale, G. L., & Alberio, L. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11506-9 · Cited by 25
Determinants of iron status and bilirubin levels in congenital dyserythropoietic anaemia type I
Wickramasinghe, Thein, Srichairatanakool, S., & Porter, J. B. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01745.x · Cited by 25
Self-citationInvited Commentary: Comparison of the Block and the Willett Food Frequency Questionnaires
Block, G. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009601 · Cited by 20
Sess, D., Carbonneau, M. A., Thomas, M., Dumon, M. F., Peuchant, E., Perromat, A., Bras, M. L., & Clerc, M. (1992) · PubMed · Cited by 9
Peroxidative damage in sickle-cell erythrocyte ghosts: protective effect of allopurinol
Sertac, A., Bingol, F., Aydin, S., & Uslu, A. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)00297-2 · Cited by 7
Cited by
Human serum albumin: From bench to bedside
Fanali, G., di Masi, A., Trezza, V., Marino, M., Fasano, M., & Ascenzi, P. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.12.002 · Cited by 1,931
The antioxidant properties of serum albumin
Roche, M., Rondeau, P., Singh, N. R., Tarnus, E., & Bourdon, E. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.04.057 · Cited by 1,255
Lipshultz, S. E., Law, Y. M., Asante-Korang, A., Austin, E. D., Dipchand, A. I., Everitt, M. D., Hsu, D. T., Lin, K. Y., Price, J. F., Wilkinson, J. D., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000682 · Cited by 416
Yazdanbakhsh, K., Ware, R. E., & Noizat-Pirenne, F. (2012) · Blood · doi:10.1182/blood-2011-11-327361 · Cited by 404
Iron-Chelating Therapy for Transfusional Iron Overload
Brittenham, G. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmct1004810 · Cited by 366
Metadata
- Authors
- Walter, P. B., Fung, E. B., Killilea, D. W., Jiang, Q., Hudes, M., Madden, J., Porter, J., Evans, P., Vichinsky, E., & Harmatz, P.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2006-09-18
- Volume
- 135
- Issue
- 2
- Pages
- 254-263
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2033392675
- Cited by
- 288
- References
- 72
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.